Is sermorelin FDA approved? No — sermorelin is not FDA-approved for human use in the U.S. Learn its legal status, research history, and safer alternatives.
No — sermorelin is not FDA-approved for human use in the United States today. Sermorelin acetate, sold under the brand name Geref, did receive FDA approval in 1997 for diagnosing and treating growth hormone deficiency in children, but the manufacturer discontinued the drug in 2002. Every sermorelin product sold in the U.S. now is either compounded or marketed as a "research chemical," which means the FDA has not reviewed it for safety, effectiveness, or manufacturing quality.
What Sermorelin Actually Is
Sermorelin is a synthetic peptide that mimics growth hormone-releasing hormone (GHRH). It signals the pituitary gland to release more growth hormone, which is why it is usually discussed alongside other peptides marketed for anti-aging, body composition, and recovery.
The FDA-approved version of sermorelin was never a general wellness product. Geref was indicated for a narrow pediatric use: evaluating and treating children with suspected growth hormone deficiency. It was given by injection under medical supervision.
The dosing, safety data, and clinical trials behind that approval apply to that specific product and that specific patient population — not to the sermorelin vials sold through telehealth clinics or research-chemical websites today.
Sermorelin's FDA History: Approved, Then Pulled
Sermorelin's approval story is unusual, and it is the reason the phrase "is sermorelin fda-approved" produces confusing answers.
- 1997: The FDA approves sermorelin acetate (Geref) for pediatric growth hormone deficiency testing and treatment.
- 2002: The manufacturer discontinues Geref. There was no safety recall — the company simply stopped making the product.
- Today: No FDA-approved sermorelin drug is on the market. The old approval is effectively dormant because no company sells an approved product.
A discontinued approval is not the same as a drug you can legally buy today. Compounded sermorelin is prepared by compounding pharmacies under different rules and has never gone through the FDA's new drug approval process.
Regulators have also raised questions about sermorelin's suitability for compounding. The FDA has placed sermorelin on lists of bulk drug substances that may not be eligible for use in compounding because of unresolved safety or effectiveness concerns.
How Sermorelin Compares to Other Peptides and GLP-1 Drugs
People researching sermorelin usually ask about a whole family of compounds. The table below summarizes where each one stands with the FDA.
| Compound | FDA-approved for human use? | Notes |
|---|---|---|
| Sermorelin (Geref) | No | Approved in 1997 for pediatric growth hormone deficiency; discontinued in 2002 and not marketed today. |
| Semaglutide (Ozempic, Wegovy) | Yes | Approved for type 2 diabetes and chronic weight management. |
| Tirzepatide (Mounjaro, Zepbound) | Yes | Approved for type 2 diabetes and chronic weight management. |
| CJC-1295 / Ipamorelin | No | Sold as research chemicals; no approved human product exists. |
| AOD-9604 | No | Studied for fat metabolism; never approved for human use in the U.S. |
| DSIP (delta sleep-inducing peptide) | No | Not approved; limited modern human data. |
| SS-31 (elamipretide) | No | Investigational; not approved for human use. |
The contrast is sharp. If you want to know is semaglutide fda-approved, the answer is a clear yes for specific indications. The same is true if you ask is tirzepatide fda approved. Growth hormone-releasing peptides like sermorelin sit in a completely different category.
Many researchers also ask is cjc-1295/ipamorelin fda-approved, and the answer is no — neither peptide has an approved human product. The same holds if you wonder is aod-9604 fda approved or is dsip fda-approved: both remain unapproved in the United States.
Why Sermorelin Still Appears in Clinics and Online
Sermorelin's reputation outlived its approval. It is marketed heavily as an "anti-aging" peptide through telehealth platforms, wellness clinics, and online peptide shops.
Most of these sellers rely on one of two workarounds:
- Compounding. A licensed pharmacy mixes sermorelin under a prescription. Compounded drugs are not FDA-approved, and they are only supposed to be used when an approved alternative does not meet a patient's needs.
- "Research chemical" labeling. The same vials are sold "for laboratory research only," which lets sellers sidestep drug rules entirely. These products are not intended for human use.
Some marketing copy leans on the phrase sermorelin peptide fda approved, but no company currently sells an FDA-approved sermorelin peptide in the U.S. Neither the compounded route nor the research-chemical route gives you the safety net of an approved drug: no reviewed manufacturing standards, no verified dosing, and no requirement to report side effects.
Risks of Using Non-FDA-Approved Sermorelin
The biggest practical risk with unapproved peptides is what you do not know about the vial.
- Purity and identity. Independent testing has repeatedly found peptides that were underdosed, mislabeled, or contaminated.
- Unknown long-term effects. Raising growth hormone levels for months or years can affect blood sugar, fluid retention, joint pain, and other systems. The data on sermorelin in healthy adults is thin.
- Monitoring gaps. Growth hormone axis drugs generally require lab monitoring by a clinician, which most online sellers do not provide.
This does not mean sermorelin is proven dangerous for everyone who uses it. It means the evidence base is limited, and the product you receive is not guaranteed to match the label.
If you are considering sermorelin, talk with a licensed healthcare professional about your goals and about what is actually approved for your situation. A clinician can also screen for conditions such as pituitary disorders that need real medical treatment rather than a peptide purchased online.
The Bottom Line on Sermorelin and FDA Approval
Sermorelin is not FDA-approved for human use in the United States today. Its only approved product, Geref, was discontinued more than two decades ago, and current supplies are compounded or research-grade.
An old approval is not the same as current availability, and "available online" is not the same as "FDA-approved." If approval status matters to you — and for injectable peptides it should — sermorelin does not currently clear that bar.
Frequently Asked Questions
Is sermorelin legal to buy in the US?
Sermorelin is not a controlled substance, but no FDA-approved sermorelin product is currently marketed in the United States. Sellers typically offer it either as a compounded prescription drug or as a "research chemical" that is not for human use. Buying a research-grade peptide for personal use means using a product the FDA has not reviewed for safety or purity.
Was sermorelin ever FDA approved?
Yes. Sermorelin acetate, sold as Geref, was FDA-approved in 1997 for evaluating and treating growth hormone deficiency in children. The manufacturer discontinued the product in 2002, so the approval is no longer backed by a marketed drug. That is why the answer to "is sermorelin FDA approved" is no today.
What is sermorelin used for now?
Sermorelin is marketed mainly for anti-aging, body composition, sleep, and recovery, usually as an injectable peptide from clinics or online sellers. Those uses are not FDA-approved and are not supported by large randomized trials in healthy adults. Anyone considering sermorelin should discuss the risks and alternatives with a licensed healthcare professional.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.